Article
African Americans with genotype 1 treated with interferon for chronic hepatitis C have a lower end of treatment response than Caucasians.
Journal of viral hepatitis - 1 Jul 2001
Kinzie J L, Naylor P H, Nathani M G, Peleman R R, Ehrinpreis M N, Lybik M, Turner J R, Janisse J J, Massanari M, Mutchnick M G
Abstract excerpt
African Americans as a group have a higher incidence of chronic hepatitis C (CHC) than Caucasians but are often under-represented in clinical trials used to define response rates to interferon therapy. The aim of this study was to compare African Americans with Caucasians with respect to end-of-treatment response to interferon. This retrospective study had 61 African Americans and 49 Caucasians with CHC. All...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.